EA200601466A1 - Новые комбинации противорвотного агента и ингибитора энкефалиназы - Google Patents

Новые комбинации противорвотного агента и ингибитора энкефалиназы

Info

Publication number
EA200601466A1
EA200601466A1 EA200601466A EA200601466A EA200601466A1 EA 200601466 A1 EA200601466 A1 EA 200601466A1 EA 200601466 A EA200601466 A EA 200601466A EA 200601466 A EA200601466 A EA 200601466A EA 200601466 A1 EA200601466 A1 EA 200601466A1
Authority
EA
Eurasian Patent Office
Prior art keywords
new combination
traffic agent
inhibitor
encephalinase
encephalinase inhibitor
Prior art date
Application number
EA200601466A
Other languages
English (en)
Other versions
EA010625B1 (ru
Inventor
Жан-Шарль Шварц
Жанн-Мари Лёкомт
Original Assignee
Биопроже
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34684783&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA200601466(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Биопроже filed Critical Биопроже
Publication of EA200601466A1 publication Critical patent/EA200601466A1/ru
Publication of EA010625B1 publication Critical patent/EA010625B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/265—Esters, e.g. nitroglycerine, selenocyanates of carbonic, thiocarbonic, or thiocarboxylic acids, e.g. thioacetic acid, xanthogenic acid, trithiocarbonic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Настоящее изобретение относится к новым комбинациям противорвотного агента и ингибитора энкефалиназы, применениям указанных комбинаций для лечения диареи и/или гастроэнтерита.
EA200601466A 2004-02-12 2005-02-14 Новые комбинации противорвотного агента и ингибитора энкефалиназы EA010625B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04290384A EP1563848A1 (en) 2004-02-12 2004-02-12 New combinations of an anti-emetic agent and an enkephalinase inhibitor
PCT/IB2005/000351 WO2005079850A1 (en) 2004-02-12 2005-02-14 New combinations of an anti emetic agent and an enkephalinase inhibitor

Publications (2)

Publication Number Publication Date
EA200601466A1 true EA200601466A1 (ru) 2006-12-29
EA010625B1 EA010625B1 (ru) 2008-10-30

Family

ID=34684783

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200601466A EA010625B1 (ru) 2004-02-12 2005-02-14 Новые комбинации противорвотного агента и ингибитора энкефалиназы

Country Status (28)

Country Link
US (1) US8222294B2 (ru)
EP (2) EP1563848A1 (ru)
JP (1) JP4987487B2 (ru)
KR (1) KR101152308B1 (ru)
CN (1) CN1917903B (ru)
AT (1) ATE468138T1 (ru)
AU (1) AU2005215262B2 (ru)
BR (1) BRPI0506631B8 (ru)
CA (1) CA2553827C (ru)
CY (1) CY1110202T1 (ru)
DE (1) DE602005021317D1 (ru)
DK (1) DK1718337T3 (ru)
EA (1) EA010625B1 (ru)
EC (1) ECSP066758A (ru)
ES (1) ES2344909T3 (ru)
HR (1) HRP20100363T1 (ru)
MA (1) MA28354A1 (ru)
ME (1) ME01175B (ru)
NO (1) NO337320B1 (ru)
NZ (1) NZ548635A (ru)
PL (1) PL1718337T3 (ru)
PT (1) PT1718337E (ru)
RS (1) RS51329B (ru)
SI (1) SI1718337T1 (ru)
TN (1) TNSN06246A1 (ru)
UA (1) UA88156C2 (ru)
WO (1) WO2005079850A1 (ru)
ZA (1) ZA200605872B (ru)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2900823B1 (fr) * 2006-05-15 2009-02-13 Bioprojet Soc Civ Ile Nouvelle forme d'administration du racecadotril.
EP2462922A1 (en) * 2010-12-10 2012-06-13 Bioprojet New form of administration of enkephalinase inhibitor
CA2877724A1 (en) * 2012-06-28 2014-01-03 Der-Yang Lee Racecadotril liquid compositions
US9114171B2 (en) * 2012-06-28 2015-08-25 Mcneil-Ppc, Inc. Racecadotril liquid compositions
US9801819B2 (en) * 2012-06-28 2017-10-31 Johnson & Johnson Consumer Inc. Racecadotril compositions
SG11201408509PA (en) 2012-06-28 2015-01-29 Mcneil Ppc Inc Racecadotril lipid compositions
MA40859A (fr) 2014-10-29 2017-09-05 Johnson & Johnson Consumer Inc Particules de cadotril

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0028575D0 (en) * 2000-11-23 2001-01-10 Elan Corp Plc Oral pharmaceutical compositions containing cyclodextrins

Also Published As

Publication number Publication date
PL1718337T3 (pl) 2010-09-30
AU2005215262A1 (en) 2005-09-01
UA88156C2 (ru) 2009-09-25
CN1917903B (zh) 2010-07-21
ECSP066758A (es) 2006-11-24
PT1718337E (pt) 2010-06-16
JP4987487B2 (ja) 2012-07-25
DE602005021317D1 (de) 2010-07-01
ES2344909T3 (es) 2010-09-09
TNSN06246A1 (fr) 2007-12-03
DK1718337T3 (da) 2010-07-26
US20070275993A1 (en) 2007-11-29
EP1563848A1 (en) 2005-08-17
CA2553827C (en) 2012-08-07
EP1718337A1 (en) 2006-11-08
BRPI0506631A (pt) 2007-05-08
SI1718337T1 (sl) 2010-08-31
WO2005079850A1 (en) 2005-09-01
JP2007522202A (ja) 2007-08-09
EP1718337B1 (en) 2010-05-19
CY1110202T1 (el) 2015-01-14
EA010625B1 (ru) 2008-10-30
US8222294B2 (en) 2012-07-17
HRP20100363T1 (hr) 2010-07-31
NO337320B1 (no) 2016-03-07
BRPI0506631B1 (pt) 2018-12-04
ZA200605872B (en) 2008-01-08
KR20060132691A (ko) 2006-12-21
NZ548635A (en) 2009-10-30
RS51329B (en) 2011-02-28
NO20063973L (no) 2006-09-05
AU2005215262B2 (en) 2011-03-03
ME01175B (me) 2013-03-20
KR101152308B1 (ko) 2012-06-11
MA28354A1 (fr) 2006-12-01
CA2553827A1 (en) 2005-09-01
CN1917903A (zh) 2007-02-21
ATE468138T1 (de) 2010-06-15
BRPI0506631B8 (pt) 2021-05-25

Similar Documents

Publication Publication Date Title
CY1110202T1 (el) Νεοι συνδυασμοι ενος αντι εμετικου παραγοντα και ενος αναστολεα της εγκεφαλινασης
EA200900781A1 (ru) 4-фенилпиран-3,5-дионы, 4-фенилтиопиран-3,5-дионы и циклогексантрионы, как новые гербициды
DK1938839T3 (da) Oftalmiske sammensætninger af parasympatiske stimulanter og anti-inflammatoriske midler til anvendelse i behandlingen af presbyopi
EA200701396A1 (ru) Триазолофталазины в качестве ингибиторов pde-2
NO20083147L (no) Anti-OX40L-antistoffer og fremgangsmater for anvendelse av disse
DK1440709T3 (da) Kombinationer, der omfatter cGMP PDE5 inhibitorer
CR9869A (es) Compuestos activos en ppar
EA201000494A1 (ru) Новые гидрокси-8-гетероарилфенантридины и их применение в качестве ингибиторов pde4
DE602004024107D1 (de) Vektoren zur gerichteten klonierung
DK1836201T4 (da) Pyrrolidininhibitorer af IAP.
EA201000888A1 (ru) 4-фенилпиран-3,5-дионы, 4-фенилтиопиран-3,5-дионы и 2-фенилциклогексан-1,3,5-трионы в качестве гербицидов
DK1682530T3 (da) Pyrrolsubstituerede indoler som inhibitorer af PAI-1
EA201270630A1 (ru) Гетероциклические сетр ингибиторы
EA200601855A1 (ru) Гербицидоактивные 3-амино-2-тиометилбензоилпиразолы
NO20075140L (no) Fremgangsmater og preparater for modulering av vaskulaer integritet
UY28344A1 (es) Nuevos compuestos
DE602006020585D1 (de) Neue cysteinproteasehemmer und ihre therapeutische anwendung
BRPI0614810A2 (pt) combinação de compostos orgánicos
WO2004105696A3 (en) Combination therapy for the treatment of neoplasms
TR200705146T1 (tr) Monoamin Yükselmesinin Engellenmesi
DK1819354T3 (da) Fremgangsmåder og forbindelser til behandling af diabetes
DE50303730D1 (de) Weiche, insbesondere zum verzweigen von schüttgutströmen
DE602004012356D1 (de) Pyrrolpolymerzusammensetzungen
SE0500291L (sv) New composition and the use thereof
CY1112773T1 (el) Χημικες ενωσεις της 4-οξαδιαζολυλ-πιπεριδινης και χρησεις αυτων

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM